We Embody a Legacy of Incredible Discoveries, Exploring the Boundaries of Innovation and Science
At Zenovel, we integrate our extensive expertise across a wide range of domains, from Good Clinical Practice to Regulatory Affairs, to present valuable insights and thought leadership. Each blog reflects our intense dedication to innovation, offering a forum to share our perspectives, groundbreaking ideas, and industry expertise. Through our blogs, we hope to uplift, inform, and support scientific, medical, and pharmaceutical innovation.
The announcement of a Good Manufacturing Practice (GMP) audit often instills anxiety among pharmaceutical, biotech, or medical device facilities. The
In the competitive landscape of life sciences, the Regulatory Affairs (RA) division has evolved from merely a compliance-related function into
In the dynamic landscape of the pharmaceutical industry, drug discovery represents only the initial phase of a much more complex
In the domain of clinical research, the announcement of a Good Clinical Practice (GCP) audit is often met with apprehension,
In the competitive and highly regulated pharmaceutical industry, the goal of growth introduces complexity in various operational areas, particularly in
For decades, the standard practice in clinical trial monitoring involved a uniform method characterized by 100% Source Data Verification (SDV)
